top biopharmaceuticals for glp-1 medication Major global pharma updates in July 2026 feature massive market movements in the obesity and segments, multi-billion dollar M&A deals, and new clinical milestones in regenerative and Prescription GLP-1s for Weight Loss

The emergence of GLP-1R as a popular target for weight loss is mainly attributed to its mechanistic features and the weight reduction efficacy shown by liraglutide and semaglutide

References: Related Articles: Top 10 Most Anticipated Drug Launches Of 2024

The authors suggest that maintaining extremely large weight losses may be harder biologically

However, it can cause steatorrhea, resulting in fat-soluble vitamin deficiency, and can even cause liver damage

Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA Compounded Semaglutide (GLP-1) Injections A once-weekly GLP-1 injection designed to help reduce appetite, improve metabolic health, and support sustainable weight loss under licensed medical supervision

But this trend reversed in 2018, with Keytrudas sales becoming higher than Opdivo's